Stoke Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 11/13/2025 | 6.87 M | $161.33 M | -7.39% | 11.76% |
| BLACKROCK, INC. | 11/12/2025 | 5.99 M | $140.70 M | 1.06% | 10.26% |
| LYNX1 CAPITAL MANAGEMENT LP | 11/13/2025 | 5.40 M | $109.88 M | 0.00% | 9.26% |
| RTW INVESTMENTS, LP | 11/14/2025 | 5.12 M | $120.40 M | 0.00% | 8.78% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 4.63 M | $108.90 M | 0.00% | 7.94% |
| REDMILE GROUP, LLC | 11/14/2025 | 4.18 M | $98.13 M | -4.58% | 7.16% |
| MORGAN STANLEY | 11/14/2025 | 3.54 M | $83.12 M | -1.03% | 6.06% |
| TORONTO DOMINION BANK | 11/14/2025 | 3.17 M | $74.57 M | 0.00% | 5.44% |
| VANGUARD GROUP INC | 11/07/2025 | 3.16 M | $74.35 M | 7.39% | 5.42% |
| SKORPIOS TRUST | 10/29/2025 | 2.26 M | $53.02 M | -30.71% | 3.87% |
| SIREN, L.L.C. | 11/13/2025 | 2.25 M | $52.81 M | 0.00% | 3.85% |
| BVF INC/IL | 11/14/2025 | 1.66 M | $38.94 M | 100.00% | 2.84% |
| STATE STREET CORP | 11/14/2025 | 1.43 M | $33.51 M | -4.12% | 2.44% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 1.32 M | $31.10 M | 49.77% | 2.27% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.31 M | $30.71 M | 100.00% | 2.24% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.15 M | $27.05 M | -11.56% | 1.97% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.15 M | $26.96 M | 17.89% | 1.97% |
| ROYAL BANK OF CANADA | 11/14/2025 | 915.79 K | $21.52 M | 535.68% | 1.57% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/07/2025 | 900.27 K | $21.16 M | 67.35% | 1.54% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 789.70 K | $18.56 M | 0.00% | 1.35% |
| MARSHALL WACE, LLP | 11/13/2025 | 768.29 K | $18.05 M | -66.60% | 1.32% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 737.75 K | $17.34 M | 438.25% | 1.26% |
| OPALEYE MANAGEMENT INC. | 11/14/2025 | 682.02 K | $16.03 M | 21.33% | 1.17% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 678.31 K | $15.95 M | 0.66% | 1.16% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 500.00 K | $11.75 M | 0.00% | 0.86% |
| CAPTION MANAGEMENT, LLC | 11/14/2025 | 500.00 K | $11.75 M | 100.00% | 0.86% |
| NORTHERN TRUST CORP | 11/14/2025 | 414.92 K | $9.75 M | -2.04% | 0.71% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 402.91 K | $9.47 M | 18.23% | 0.69% |
| ERSTE ASSET MANAGEMENT GMBH | 11/12/2025 | 396.00 K | $9.79 M | 0.00% | 0.68% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 334.48 K | $7.86 M | 1,669.74% | 0.57% |
| UBS GROUP AG | 11/13/2025 | 306.04 K | $7.19 M | -13.23% | 0.52% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 253.90 K | $5.97 M | -52.31% | 0.44% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2025 | 250.00 K | $5.88 M | 100.00% | 0.43% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 250.00 K | $5.88 M | 100.00% | 0.43% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 249.45 K | $5.86 M | -54.49% | 0.43% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2025 | 238.02 K | $5.59 M | 36.23% | 0.41% |
| CHECKPOINT CAPITAL L.P. | 11/14/2025 | 212.05 K | $4.98 M | 100.00% | 0.36% |
| BIRCHVIEW CAPITAL, LP | 11/13/2025 | 210.00 K | $4.94 M | 0.00% | 0.36% |
| INVESCO LTD. | 11/13/2025 | 208.08 K | $4.89 M | 417.51% | 0.36% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2025 | 169.79 K | $3.99 M | -66.18% | 0.29% |
| GILDER GAGNON HOWE & CO LLC | 11/14/2025 | 155.17 K | $3.65 M | 19.75% | 0.27% |
| FIRST TRUST ADVISORS LP | 11/12/2025 | 152.30 K | $3.58 M | 100.00% | 0.26% |
| PENSERRA CAPITAL MANAGEMENT LLC | 11/04/2025 | 150.60 K | $3.54 M | 100.00% | 0.26% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 11/14/2025 | 126.35 K | $2.97 M | 0.00% | 0.22% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 120.44 K | $2.83 M | 16.06% | 0.21% |
| EAM INVESTORS, LLC | 11/14/2025 | 120.18 K | $2.78 M | 100.00% | 0.21% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 115.83 K | $2.72 M | 42.31% | 0.20% |
| BARCLAYS PLC | 11/12/2025 | 107.72 K | $2.53 M | -23.00% | 0.18% |
| NUVEEN, LLC | 11/12/2025 | 105.99 K | $2.49 M | 3.44% | 0.18% |
| PALO ALTO INVESTORS LP | 11/14/2025 | 105.43 K | $2.48 M | -16.24% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Stoke Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 179 institutional investors and hedge funds held shares of Stoke Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 6.87 M
BlackRock, Inc.: 5.99 M
Lynx1 Capital Management LP: 5.4 M
RTW INVESTMENTS, LP: 5.12 M
BAKER BROS. ADVISORS LP: 4.63 M
Redmile Group, LLC: 4.18 M
116.01% of Stoke Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 93.62 M shares in the last 24 months. This purchase volume represents approximately $2.90 B in transactions.